{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:02Z","timestamp":1759333622594},"reference-count":26,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Rev Anticancer Ther"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1586\/14737140.7.11.1665","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T16:26:57Z","timestamp":1195230417000},"page":"1665-1674","source":"Crossref","is-referenced-by-count":7,"title":["Molecular staging for patients with malignant melanoma"],"prefix":"10.1586","volume":"7","author":[{"given":"Steve","family":"Shivers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Jakub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Pendas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Reintgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"ref-1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930515)71:10<2995::AID-CNCR2820711018>3.0.CO;2-P"},{"key":"ref-2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198808000-00002"},{"key":"ref-3","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199111000-00015"},{"key":"ref-4","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199609000-00002"},{"key":"ref-5","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198808000-00002"},{"key":"ref-6","unstructured":"Bleicher RJ, Foshag LJ, Essner R, Wanek LA, Morton DL. Sentinel node positivity and characteristics of 'thin'invasive cutaneous melanomas. Presented at:The 54th Annual Cancer Symposium, Society of Surgical Oncology.Washington, DC, USA, 15-18 March 2001 (Abstract)."},{"key":"ref-7","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900815)66:4<765::AID-CNCR2820660428>3.0.CO;2-M"},{"key":"ref-8","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199412000-00010"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Dessureault S, Soong S, Ross Met al.Improved survival for node-negative patients with intermediate-to-thick melanomas (>1.0 mm) staged with sentinel lymph node (SLN) biopsy. Presented at:The 54th Annual Cancer Symposium, Society of Surgical Oncology.Washington, DC, USA, 15-18 March 2001 (Abstract).","DOI":"10.1245\/aso.2001.8.10.766"},{"key":"ref-10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.16.1410"},{"key":"ref-11","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-199201000-00010"},{"key":"ref-12","first-page":"153","volume":"84","author":"Messina","year":"1997","journal-title":"J. Florida Med. Assoc."},{"key":"ref-13","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200006000-00003"},{"key":"ref-14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archsurg.1991.01410360025005","volume":"126","author":"Heller","year":"1991","journal-title":"Arch. Surg."},{"key":"ref-15","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-199201000-00019"},{"key":"ref-16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/j.1098-2388.1993.tb00022.x","volume":"9","author":"Heller","year":"1993","journal-title":"Semin. Surg. Oncol."},{"key":"ref-17","unstructured":"Shivers S, Hoffman S, Lin J, Li W, Stafford M, Reintgen DS. Low specificity for detection of sentinel node micrometastases by a nested RT-PCR assay for tyrosinase in melanoma patients. Presented at:The 54th Annual Cancer Symposium, Society of Surgical Oncology.Washington, DC, USA, 15-18 March 2001 (Abstract)."},{"key":"ref-18","unstructured":"McMasters KM, Edwards M, Ross Met al.SunBelt Melanoma Trial. Frequency of non-sentinel lymph node metastases in melanoma. Presented at:The 54th Annual Cancer Symposium, Society of Surgical Oncology.Washington, DC, USA, 15-18 March 2001 (Abstract)."},{"key":"ref-19","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-999-0232-z"},{"key":"ref-20","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.1999.17.10.3238","volume":"17","author":"Bostick","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref-21","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(98)00138-0"},{"key":"ref-22","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1200\/JCO.1999.17.8.2562","volume":"17","author":"Curry","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref-23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2342"},{"key":"ref-24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"ref-25","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.1996.14.7.2091","volume":"14","author":"Mellado","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"ref-26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.4573"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T19:42:44Z","timestamp":1684093364000},"score":1,"resource":{"primary":{"URL":"http:\/\/informahealthcare.com\/doi\/abs\/10.1586\/14737140.7.11.1665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1586\/14737140.7.11.1665"],"URL":"https:\/\/doi.org\/10.1586\/14737140.7.11.1665","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}